Articles from Morris & Dickson

Morris & Dickson announced today that it is now licensed to deliver pharmaceuticals and related products to health systems, independent pharmacies, specialty pharmacies and alternative care facilities across all 50 states. With a 180-plus year reputation as the leading pharmaceutical distributor in the south-central region of the United States, this national expansion signifies a milestone in M&D’s growth strategy with the ability to serve pharmacies across all sites of care nationally.

Morris & Dickson today announces the formation of their 2025 Health System Advisory Board to advise and guide the company in its delivery of pharmaceuticals and services to healthcare providers across the country.

Morris & Dickson today announces that Vinu V. Pillai has joined the company as its chief compliance and regulatory officer. In this role, Pillai will have responsibility for Morris & Dickson’s overall compliance and regulatory functions including ethics management, risk management, suspicious order monitoring, Drug Supply Chain Security Act (DSCSA) oversight, regulatory oversight and licensing, and he will report to Jody Hatcher, president and CEO.

Morris & Dickson, a leading pharmaceutical distributor, has unveiled a groundbreaking solution for the transportation of temperature-sensitive medications to customer pharmacies. Leveraging cutting-edge technology, the company has implemented Coldtainer and Aerosafe containers to ensure the safe and precise delivery of climate-controlled medications.

Morris & Dickson is proud to announce it is the first U.S. distributor of Bavarian Nordic’s newly launched mpox vaccine, JYNNEOS®. As the only FDA-approved mpox vaccine, JYNNEOS is now commercially available in the U.S., marking a significant expansion for access.